CANCER IN PATIENTS RECEIVING LONG-TERM DIALYSIS TREATMENT

被引：61

作者：

KANTOR, AF

HOOVER, RN

KINLEN, LJ

MCMULLAN, MR

FRAUMENI, JF

机构：

[1] NCI,ENVIRONM EPIDEMIOL BRANCH,BETHESDA,MD 20205

[2] UNIV OXFORD,RADCLIFFE INFIRM,OXFORD OX2 6HE,ENGLAND

[3] HLTH CARE FINANCING ADM,BALTIMORE,MD

来源：

关键词：

D O I：

10.1093/oxfordjournals.aje.a114668

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：370 / 376

页数：7

共 25 条

[1] BEASLEY RP, 1981, LANCET, V2, P1129
[2] OVER 50 AND UREMIC = DEATH - THE FAILURE OF THE BRITISH-NATIONAL-HEALTH-SERVICE TO PROVIDE ADEQUATE DIALYSIS FACILITIES
BERLYNE, GM
[J]. NEPHRON, 1982, 31 (03): : 189 - 190
[3] UREMIA AS A STATE OF IMMUNE DEFICIENCY
BIRKELAND, SA
[J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1976, 5 (1-2) : 107 - 115
[4] BIRKELAND SA, 1983, CANCER, V51, P1571, DOI 10.1002/1097-0142(19830501)51:9<1571::AID-CNCR2820510903>3.0.CO
[5] 2-S
[6] HOST DEFENSES AND IMMUNOLOGICAL ALTERATIONS ASSOCIATED WITH CHRONIC-HEMODIALYSIS
GOLDBLUM, SE
REED, WP
[J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (04) : 597 - 613
[7] MALIGNANCY IN UREMIA - DIALYSIS VERSUS TRANSPLANTATION
HERR, HW
ENGEN, DE
HOSTETLER, J
[J]. JOURNAL OF UROLOGY, 1979, 121 (05) : 584 - 586
[8] HOOVER R, 1973, LANCET, V2, P55
[9] HOOVER R, UNPUB CANCER RISKS R
[10] HURWICH BJ, 1975, LANCET, V2, P716